HEADER CYTOSOLIC PROTEIN 22-JUN-23 7G8W TITLE ARHGEF2 PANDDA ANALYSIS GROUP DEPOSITION -- ARHGEF2 AND RHOA IN TITLE 2 COMPLEX WITH Z1416193393 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSFORMING PROTEIN RHOA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RHO CDNA CLONE 12,H12; COMPND 5 EC: 3.6.5.2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: GUANINE NUCLEOTIDE EXCHANGE FACTOR H1,GEF-H1,MICROTUBULE- COMPND 11 REGULATED RHO-GEF,PROLIFERATING CELL NUCLEOLAR ANTIGEN P40; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RHOA, ARH12, ARHA, RHO12; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ARHGEF2, KIAA0651, LFP40; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SGC - DIAMOND I04-1 FRAGMENT SCREENING, PANDDA, XCHEMEXPLORER, KEYWDS 2 CYTOSOLIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR W.J.BRADSHAW,V.L.KATIS,C.BOUNTRA,F.VON DELFT,P.E.BRENNAN REVDAT 2 22-MAY-24 7G8W 1 REMARK REVDAT 1 12-JUL-23 7G8W 0 JRNL AUTH W.J.BRADSHAW,V.L.KATIS,C.BOUNTRA,F.VON DELFT,P.E.BRENNAN JRNL TITL ARHGEF2 PANDDA ANALYSIS GROUP DEPOSITION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 (17-FEB-2023) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 38631 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1922 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.77 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 773 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 737 REMARK 3 BIN R VALUE (WORKING SET) : 0.3669 REMARK 3 BIN FREE R VALUE : 0.3711 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.66 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 36 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3427 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 368 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.46720 REMARK 3 B22 (A**2) : -1.46720 REMARK 3 B33 (A**2) : 2.93450 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.190 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.165 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.172 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.157 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3785 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5125 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1437 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 671 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3785 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 488 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3220 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.79 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.22 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 10.2702 -29.7571 11.1705 REMARK 3 T TENSOR REMARK 3 T11: 0.0061 T22: 0.0021 REMARK 3 T33: -0.0925 T12: -0.0174 REMARK 3 T13: 0.0018 T23: -0.0043 REMARK 3 L TENSOR REMARK 3 L11: 0.6570 L22: 0.5290 REMARK 3 L33: 1.5469 L12: -0.2761 REMARK 3 L13: 0.6308 L23: -0.4882 REMARK 3 S TENSOR REMARK 3 S11: -0.0294 S12: -0.0029 S13: 0.0191 REMARK 3 S21: -0.0097 S22: 0.0096 S23: 0.0015 REMARK 3 S31: -0.0507 S32: 0.0713 S33: 0.0197 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.3534 -41.3717 32.5355 REMARK 3 T TENSOR REMARK 3 T11: 0.0092 T22: 0.0289 REMARK 3 T33: -0.0777 T12: -0.0134 REMARK 3 T13: -0.0018 T23: 0.0063 REMARK 3 L TENSOR REMARK 3 L11: 0.2733 L22: 0.4093 REMARK 3 L33: 0.3932 L12: -0.0456 REMARK 3 L13: -0.0041 L23: 0.2025 REMARK 3 S TENSOR REMARK 3 S11: -0.0059 S12: 0.0141 S13: -0.0135 REMARK 3 S21: -0.0139 S22: 0.0195 S23: 0.0119 REMARK 3 S31: 0.0063 S32: 0.0249 S33: -0.0136 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7G8W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1001405881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.92124 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38770 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 71.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 26.60 REMARK 200 R MERGE (I) : 0.78000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 28.00 REMARK 200 R MERGE FOR SHELL (I) : 8.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 8BNT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS, 2.6M SODIUM FORMATE, PH REMARK 280 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 98.16800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.71500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 147.25200 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.71500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.08400 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.71500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.71500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 147.25200 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.71500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.71500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 49.08400 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 98.16800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 O1 FMT B 505 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ARG A 182 REMARK 465 ARG A 183 REMARK 465 GLY A 184 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 40 -73.91 -79.64 REMARK 500 LYS A 164 -5.95 71.84 REMARK 500 PHE B 261 -72.75 -81.02 REMARK 500 PHE B 280 67.25 -117.76 REMARK 500 CYS B 282 16.65 57.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 423 DISTANCE = 5.96 ANGSTROMS DBREF 7G8W A 1 184 UNP P61586 RHOA_HUMAN 1 184 DBREF 7G8W B 206 448 UNP Q92974 ARHG2_HUMAN 206 448 SEQADV 7G8W SER A 0 UNP P61586 EXPRESSION TAG SEQADV 7G8W SER B 204 UNP Q92974 EXPRESSION TAG SEQADV 7G8W MET B 205 UNP Q92974 EXPRESSION TAG SEQRES 1 A 185 SER MET ALA ALA ILE ARG LYS LYS LEU VAL ILE VAL GLY SEQRES 2 A 185 ASP GLY ALA CYS GLY LYS THR CYS LEU LEU ILE VAL PHE SEQRES 3 A 185 SER LYS ASP GLN PHE PRO GLU VAL TYR VAL PRO THR VAL SEQRES 4 A 185 PHE GLU ASN TYR VAL ALA ASP ILE GLU VAL ASP GLY LYS SEQRES 5 A 185 GLN VAL GLU LEU ALA LEU TRP ASP THR ALA GLY GLN GLU SEQRES 6 A 185 ASP TYR ASP ARG LEU ARG PRO LEU SER TYR PRO ASP THR SEQRES 7 A 185 ASP VAL ILE LEU MET CYS PHE SER ILE ASP SER PRO ASP SEQRES 8 A 185 SER LEU GLU ASN ILE PRO GLU LYS TRP THR PRO GLU VAL SEQRES 9 A 185 LYS HIS PHE CYS PRO ASN VAL PRO ILE ILE LEU VAL GLY SEQRES 10 A 185 ASN LYS LYS ASP LEU ARG ASN ASP GLU HIS THR ARG ARG SEQRES 11 A 185 GLU LEU ALA LYS MET LYS GLN GLU PRO VAL LYS PRO GLU SEQRES 12 A 185 GLU GLY ARG ASP MET ALA ASN ARG ILE GLY ALA PHE GLY SEQRES 13 A 185 TYR MET GLU CYS SER ALA LYS THR LYS ASP GLY VAL ARG SEQRES 14 A 185 GLU VAL PHE GLU MET ALA THR ARG ALA ALA LEU GLN ALA SEQRES 15 A 185 ARG ARG GLY SEQRES 1 B 245 SER MET GLU MET ASP GLU LYS ASP PHE ALA ALA ASP SER SEQRES 2 B 245 TRP SER LEU ALA VAL ASP SER SER PHE LEU GLN GLN HIS SEQRES 3 B 245 LYS LYS GLU VAL MET LYS GLN GLN ASP VAL ILE TYR GLU SEQRES 4 B 245 LEU ILE GLN THR GLU LEU HIS HIS VAL ARG THR LEU LYS SEQRES 5 B 245 ILE MET THR ARG LEU PHE ARG THR GLY MET LEU GLU GLU SEQRES 6 B 245 LEU HIS LEU GLU PRO GLY VAL VAL GLN GLY LEU PHE PRO SEQRES 7 B 245 CYS VAL ASP GLU LEU SER ASP ILE HIS THR ARG PHE LEU SEQRES 8 B 245 SER GLN LEU LEU GLU ARG ARG ARG GLN ALA LEU CYS PRO SEQRES 9 B 245 GLY SER THR ARG ASN PHE VAL ILE HIS ARG LEU GLY ASP SEQRES 10 B 245 LEU LEU ILE SER GLN PHE SER GLY PRO SER ALA GLU GLN SEQRES 11 B 245 MET CYS LYS THR TYR SER GLU PHE CYS SER ARG HIS SER SEQRES 12 B 245 LYS ALA LEU LYS LEU TYR LYS GLU LEU TYR ALA ARG ASP SEQRES 13 B 245 LYS ARG PHE GLN GLN PHE ILE ARG LYS VAL THR ARG PRO SEQRES 14 B 245 ALA VAL LEU LYS ARG HIS GLY VAL GLN GLU CYS ILE LEU SEQRES 15 B 245 LEU VAL THR GLN ARG ILE THR LYS TYR PRO LEU LEU ILE SEQRES 16 B 245 SER ARG ILE LEU GLN HIS SER HIS GLY ILE GLU GLU GLU SEQRES 17 B 245 ARG GLN ASP LEU THR THR ALA LEU GLY LEU VAL LYS GLU SEQRES 18 B 245 LEU LEU SER ASN VAL ASP GLU GLY ILE TYR GLN LEU GLU SEQRES 19 B 245 LYS GLY ALA ARG LEU GLN GLU ILE TYR ASN ARG HET Z6I A 201 12 HET DMS A 202 4 HET FMT A 203 3 HET FMT A 204 3 HET FMT A 205 3 HET FMT A 206 3 HET FMT A 207 3 HET DMS B 501 4 HET DMS B 502 4 HET DMS B 503 4 HET DMS B 504 4 HET FMT B 505 3 HET FMT B 506 3 HET FMT B 507 3 HET FMT B 508 3 HET FMT B 509 3 HET FMT B 510 3 HET FMT B 511 3 HET FMT B 512 3 HETNAM Z6I 4-(5-METHYL-1H-PYRAZOL-4-YL)PIPERIDINE HETNAM DMS DIMETHYL SULFOXIDE HETNAM FMT FORMIC ACID FORMUL 3 Z6I C9 H15 N3 FORMUL 4 DMS 5(C2 H6 O S) FORMUL 5 FMT 13(C H2 O2) FORMUL 22 HOH *368(H2 O) HELIX 1 AA1 GLY A 17 ASP A 28 1 12 HELIX 2 AA2 LEU A 69 TYR A 74 5 6 HELIX 3 AA3 SER A 88 LYS A 98 1 11 HELIX 4 AA4 LYS A 98 CYS A 107 1 10 HELIX 5 AA5 LYS A 118 ASN A 123 5 6 HELIX 6 AA6 ASP A 124 LYS A 133 1 10 HELIX 7 AA7 LYS A 140 GLY A 152 1 13 HELIX 8 AA8 GLY A 166 GLN A 180 1 15 HELIX 9 AA9 MET B 205 PHE B 212 1 8 HELIX 10 AB1 SER B 216 VAL B 221 1 6 HELIX 11 AB2 ASP B 222 GLN B 227 1 6 HELIX 12 AB3 LYS B 230 LEU B 260 1 31 HELIX 13 AB4 PHE B 261 LEU B 269 1 9 HELIX 14 AB5 GLY B 274 PHE B 280 1 7 HELIX 15 AB6 CYS B 282 ALA B 304 1 23 HELIX 16 AB7 ARG B 317 PHE B 326 1 10 HELIX 17 AB8 SER B 327 ASP B 359 1 33 HELIX 18 AB9 ASP B 359 ARG B 371 1 13 HELIX 19 AC1 PRO B 372 LYS B 376 5 5 HELIX 20 AC2 GLY B 379 HIS B 404 1 26 HELIX 21 AC3 ILE B 408 GLY B 432 1 25 HELIX 22 AC4 ARG B 441 ASN B 447 1 7 SHEET 1 AA1 6 TYR A 42 VAL A 48 0 SHEET 2 AA1 6 LYS A 51 ASP A 59 -1 O VAL A 53 N ILE A 46 SHEET 3 AA1 6 ILE A 4 VAL A 11 1 N ILE A 4 O GLU A 54 SHEET 4 AA1 6 VAL A 79 SER A 85 1 O CYS A 83 N VAL A 11 SHEET 5 AA1 6 ILE A 112 ASN A 117 1 O ASN A 117 N PHE A 84 SHEET 6 AA1 6 GLY A 155 GLU A 158 1 O MET A 157 N GLY A 116 CRYST1 71.430 71.430 196.336 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014000 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005093 0.00000